← Evidence map

TrialBMC cancer2011

PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib.

Leiping Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

77 papers cite itlatest 60 shown

2011
…
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 21676217